Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).

Broad endorsement for insurance-covered blood-based CRC screening (92%) suggests payer policy could materially influence uptake among guideline-eligible, average-risk adults starting at age 45.

The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based ...

The American Cancer Society has added blood tests every three years as a new option for colorectal cancer screening, in addition to colonoscopy and stool tests. While invasive, colonoscopy remains the ...

A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study. A noninvasive colorectal cancer screening ...

Hearing tests can be classified into two main types: diagnostic and screening. Screening tests that employ pure tone audiometry via basic air conduction are utilized to rapidly assess whether more ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard ...